The amazing and inspiring Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, former Physician-in-Chief of MSKCC, and someone who has held way too many national titles to count, debated with me some of the ideas laid out in his book, “The Death of Cancer,” most notably the utility of randomized controlled trials in regulatory approvals.
As a lymphoma specialist, this episode was a highlight of my podcasting career; speaking with a legend that I have always admired from afar. What a treat. Listen and let me know what you think.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
